<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01176721</url>
  </required_header>
  <id_info>
    <org_study_id>02VNS2009</org_study_id>
    <nct_id>NCT01176721</nct_id>
  </id_info>
  <brief_title>Transcutaneous Non-invasive Vagus Nerve Stimulation (t-VNS) in the Treatment of Schizophrenia</brief_title>
  <acronym>02VNS2009</acronym>
  <official_title>Transcutaneous Non-invasive Vagus Nerve Stimulation (t-VNS) in the Treatment of Schizophrenia: a Randomized, Controlled, Double Blind, Two-armed Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>cerbomed GmbH</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>cerbomed GmbH</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized, controlled, double-blind, two-armed clinical investigation to show the efficacy
      and safety of transcutaneous vagus nerve stimulation (t-VNS), applied at the left auricle, in
      schizophrenia.

      Study hypothesis: t-VNS may improve negative symptoms, depressive symptoms, cognitive
      impairment,and aggressive behavior of treated schizophrenia patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2010</start_date>
  <completion_date type="Actual">February 2012</completion_date>
  <primary_completion_date type="Actual">July 2011</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Safety and efficacy of t-VNS in schizophrenia</measure>
    <time_frame>24 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Recording of clinical performance of t-VNS in schizophrenia</measure>
    <time_frame>24 weeks</time_frame>
    <description>self rating:
BDI
Fagerström
rating by investigator
UKU
SANS
CDSS
MARDS
HAMD-21
CGI
PSP
SWN_K
St. Hans
VLMT
TMT-B
TMT-A
RWT
Corsi Block Tapping
Zahlennachsprechen
MWT-B
EKT
HR
dTMS</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Schizophrenia</condition>
  <arm_group>
    <arm_group_label>t-VNS verum</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Active stimulation of the left auricle by t-VNS</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Sham-simulation of the left auricle by the t-VNS device.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>t-VNS verum</intervention_name>
    <description>Active stimulation of the left auricle by t-VNS</description>
    <arm_group_label>t-VNS verum</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>t-VNS placebo</intervention_name>
    <description>Sham stimulation of the left auricle with the t-VNS device</description>
    <arm_group_label>Sham</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of a schizophrenic disorder (F20 according to ICD-10),duration of disease ≥
             12 months

          -  Appliance of the t-VNS® medical device according to the manual

        Exclusion Criteria:

          -  Improvent of the PANSS score within the period of 2 - 4 weeks from screening to the
             baseline

          -  Pregnancy

          -  Bronchial asthhma in medical history

          -  clinically relevant internistic, neurological or psychiatric diseases

          -  abuse of drugs or alcohol until 4 weeks to enrollment

          -  Traumatic brain injury in medical history as well as invasive and non-invasive methods
             of treatment (e.g. tumor surgery (Gammma knife surgery))

          -  indication of structural impairment of the basal ganglia or the brain stem

          -  malformations of the pinna

          -  further circumstances that at the discretion of the investigator will not allow to
             include the subject into the clinical study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-Universitaet Muenchen</name>
      <address>
        <city>Munich</city>
        <state>Bavaria</state>
        <zip>80336</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Departement of Psychiatry and Psychotherapy, University Hospital of Goettingen</name>
      <address>
        <city>Goettingen</city>
        <state>Niedersachsen</state>
        <zip>37075</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 5, 2010</study_first_submitted>
  <study_first_submitted_qc>August 5, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 6, 2010</study_first_posted>
  <last_update_submitted>September 11, 2012</last_update_submitted>
  <last_update_submitted_qc>September 11, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 12, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>schizophrenic disorders</keyword>
  <keyword>psychosis</keyword>
  <keyword>psychotic</keyword>
  <keyword>dementia</keyword>
  <keyword>delusional</keyword>
  <keyword>delusions</keyword>
  <keyword>hallucinations</keyword>
  <keyword>residual-type schizophrenia</keyword>
  <keyword>illusions</keyword>
  <keyword>split mind</keyword>
  <keyword>mental health disorder</keyword>
  <keyword>schizoid</keyword>
  <keyword>paranoid-type schizophrenia</keyword>
  <keyword>disorganized-type schizophrenia</keyword>
  <keyword>undifferentiated-type schizophrenia</keyword>
  <keyword>catatonic-type schizophrenia</keyword>
  <keyword>mental illness</keyword>
  <keyword>tardive dyskinesia</keyword>
  <keyword>neuroleptic malignant syndrome</keyword>
  <keyword>NMS</keyword>
  <keyword>antipsychotics</keyword>
  <keyword>atypical antipsychotics</keyword>
  <keyword>psychosocial treatments</keyword>
  <keyword>rehabilitation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Schizophrenia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

